ReviewExperimental neurobiology2017

Toll-like Receptor 2: A Novel Therapeutic Target for Ischemic White Matter Injury and Oligodendrocyte Death.

Jun Young Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.